Skip to Main Content

Author Details

Christopher McCabe
Queens University Belfast
1996
153
39
Vardit Ravitsky (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
38048985Logical Inconsistencies in the Health Years in Total and Equal Value of Life-Years Gained.Value Health2024
36792322Global evidence of gender equity in academic health research: a scoping review.BMJ Open2023
37752732We need to talk about values: a proposed framework for the articulation of normative reasoning in health technology assessment.Health Econ Policy Law2023
35260100PSMA PET/CT guided intensification of therapy in patients at risk of advanced prostate cancer (PATRON): a pragmatic phase III randomized controlled trial.BMC Cancer2022
35779939A Conceptual Framework for Life-Cycle Health Technology Assessment.Value Health2022
35319446The Importance of and Challenges with Adopting Life-Cycle Regulation and Reimbursement in Canada.Healthc Policy2022
35279178Impact of an addiction medicine consult team intervention in a Canadian inner city hospital on acute care utilization: a pragmatic quasi-experimental study.Subst Abuse Treat Prev Policy2022
35279142Reducing readmission rates for individuals discharged from acute psychiatric care in Alberta using peer and text message support: Protocol for an innovative supportive program.BMC Health Serv Res2022
35216902Defining a Core Data Set for the Economic Evaluation of Precision Oncology.Value Health2022
33225423Probabilistic One-Way Sensitivity Analysis with Multiple Comparators: The Conditional Net Benefit Frontier.Pharmacoeconomics2021
36962089Vaccine rollout strategies: The case for vaccinating essential workers early.PLOS Glob Public Health2021
33517512Modifying NICE's Approach to Equity Weighting.Pharmacoeconomics2021
33583478Status of primary and secondary mental healthcare of people with severe mental illness: an epidemiological study from the UK PARTNERS2 programme.BJPsych Open2021
34016154Correction to: A novel preference-informed complementary trial (PICT) design for clinical trial research influenced by strong patient preferences.Trials2021
34138458A Net Benefit Approach for the Optimal Allocation of a COVID-19 Vaccine.Pharmacoeconomics2021
33462758NICE's Discounting Review: Clear Thinking on Rational Revision Meets Obstacle of Industrial Interests.Pharmacoeconomics2021
31130722Cost-effectiveness analysis of multigene expression profiling assays to guide adjuvant therapy decisions in women with invasive early-stage breast cancer.Pharmacogenomics J2020
31840216One-Way Sensitivity Analysis for Probabilistic Cost-Effectiveness Analysis: Conditional Expected Incremental Net Benefit.Pharmacoeconomics2020
31959155Social values for health technology assessment in Canada: a scoping review of hepatitis C screening, diagnosis and treatment.BMC Public Health2020
32880572Six versus 12 months' adjuvant trastuzumab in patients with HER2-positive early breast cancer: the PERSEPHONE non-inferiority RCT.Health Technol Assess2020
32460879Multi-dose Oral Ondansetron for Pediatric Gastroenteritis: study Protocol for the multi-DOSE oral ondansetron for pediatric Acute GastroEnteritis (DOSE-AGE) pragmatic randomized controlled trial.Trials2020
32565458Study protocol for two complementary trials of non-steroidal or opioid analgesia use for children aged 6 to 17 years with musculoskeletal injuries (the No OUCH study).BMJ Open2020
30328562Expanding the Scope of Costs and Benefits for Economic Evaluations in Health: Some Words of Caution.Pharmacoeconomics2019
31860422Cost-effectiveness analysis of metformin with enzalutamide in the metastatic castrate-resistant prostate cancer setting.Can J Urol2019
30056180Early Initiation of Tumor Necrosis Factor Antagonist-Based Therapy for Patients With Crohn's Disease Reduces Costs Compared With Late Initiation.Clin Gastroenterol Hepatol2019
31559948Comparing alternating pressure mattresses and high-specification foam mattresses to prevent pressure ulcers in high-risk patients: the PRESSURE 2 RCT.Health Technol Assess2019
31505957Hard choices: Reflections from the tomb of the unknown patient.Healthc Manage Forum2019
30616552Refining a model of collaborative care for people with a diagnosis of bipolar, schizophrenia or other psychoses in England: a qualitative formative evaluation.BMC Psychiatry2019
28784564Cell-Free DNA-Based Non-invasive Prenatal Screening for Common Aneuploidies in a Canadian Province: A Cost-Effectiveness Analysis.J Obstet Gynaecol Can2018
30149879Balancing the Economics and Ethics of Personalised Oncology.Trends Cancer2018
29900829Alternative tumour necrosis factor inhibitors (TNFi) or abatacept or rituximab following failure of initial TNFi in rheumatoid arthritis: the SWITCH RCT.Health Technol Assess2018
30224108Using "Big Data" in the Cost-Effectiveness Analysis of Next-Generation Sequencing Technologies: Challenges and Potential Solutions.Value Health2018
30420734Addendum: Low-value approvals and high prices might incentivize ineffective drug development.Nat Rev Clin Oncol2018
29382312Stem cells and beta cell replacement therapy: a prospective health technology assessment study.BMC Endocr Disord2018
29460413Bayesian statistical models to estimate EQ-5D utility scores from EORTC QLQ data in myeloma.Pharm Stat2018
29760505Low-value approvals and high prices might incentivize ineffective drug development.Nat Rev Clin Oncol2018
29319484Pitfalls of prioritizing cost-effectiveness in the assessment of medical innovation: A comment on Wallis and Detsky guest editorial.Can Urol Assoc J2018
27553208Determinants of Change in the Cost-effectiveness Threshold.Med Decis Making2017
28488257A Comparison of Four Software Programs for Implementing Decision Analytic Cost-Effectiveness Models.Pharmacoeconomics2017
28277530Show drugs work before selling them.Nature2017
28393757Prehospital randomised assessment of a mechanical compression device in out-of-hospital cardiac arrest (PARAMEDIC): a pragmatic, cluster randomised trial and economic evaluation.Health Technol Assess2017
29241890Value of Information Analysis of Multiparameter Tests for Chemotherapy in Early Breast Cancer: The OPTIMA Prelim Trial.Value Health2017
28881249Cost-effectiveness analysis of PET-CT-guided management for locally advanced head and neck cancer.Eur J Cancer2017
28555115Long-term Results from the Empowering a Multimodal Pathway Toward Healthy Youth Program, a Multimodal School-Based Approach, Show Marked Reductions in Suicidality, Depression, and Anxiety in 6,227 Students in Grades 6-12 (Aged 11-18).Front Psychiatry2017
28679655Marketing of unproven stem cell-based interventions: A call to action.Sci Transl Med2017
27943173Discounting the Recommendations of the Second Panel on Cost-Effectiveness in Health and Medicine.Pharmacoeconomics2017
26867046OPTIMA prelim: a randomised feasibility study of personalised care in the treatment of women with early breast cancer.Health Technol Assess2016
26520836A Review of "The New Drug Reimbursement Game: A Regulator's Guide to Playing and Winning".Appl Health Econ Health Policy2016
27525106One-year resource utilisation, costs and quality of life in patients with acute respiratory distress syndrome (ARDS): secondary analysis of a randomised controlled trial.J Intensive Care2016
27185282Setting Global Standards for Stem Cell Research and Clinical Translation: The 2016 ISSCR Guidelines.Stem Cell Reports2016
  • 1 - 50 of 153

Recommended Authors

Nathaniel Hendrix
Harvard T.H. Chan School of Public Health
Career Start Year 2017
Number of shared co-authors 0
Thomas Butt
UCL Institute of Ophthalmology, University College London
Career Start Year 2013
Number of shared co-authors 1
Seamus Kent
National Institute for Health and Care Excellence
Career Start Year 2013
Number of shared co-authors 1
Dalia Dawoud
Stanford University
Career Start Year 2010
Number of shared co-authors 1
Benjamin P Geisler
Massachusetts General Hospital, Harvard Medical School
Career Start Year 2008
Number of shared co-authors 0
Christine Y Lu
Harvard Medical School and the Harvard Pilgrim Health Care Institute
Career Start Year 2004
Number of shared co-authors 1
Nicholas Mitsakakis
Institute of Health Policy Management and Evaluation, University of Toronto
Career Start Year 2003
Number of shared co-authors 1
Joseph S Ross
Yale School of Medicine
Career Start Year 1999
Number of shared co-authors 2
Victor M Montori
Knowledge and Evaluation Research Unit in Endocrinology (KER_Endo), Mayo Clinic
Career Start Year 1998
Number of shared co-authors 1
Emily Beth Devine
University of Washington
Career Start Year 1997
Number of shared co-authors 0
Maarten J IJzerman
Technical Medical Centre, University of Twente
Career Start Year 1997
Number of shared co-authors 3
Andrew Walker
University of California San Diego
Career Start Year 1995
Number of shared co-authors 0
Mireille Goetghebeur
School of Public Health, Universite de Montreal 1
Career Start Year 1995
Number of shared co-authors 0
David O Meltzer
The University of Chicago
Career Start Year 1993
Number of shared co-authors 0
Ben van Hout
University of Sheffield
Career Start Year 1993
Number of shared co-authors 0
Jason N Doctor
University of Southern California
Career Start Year 1992
Number of shared co-authors 0
Dana P Goldman
University of Southern California
Career Start Year 1992
Number of shared co-authors 1
David L Veenstra
University of Washington
Career Start Year 1992
Number of shared co-authors 2
Chris L Pashos
Data Sciences Institute, Takeda Pharmaceuticals International Inc.
Career Start Year 1990
Number of shared co-authors 0
David A Asch
University of Pennsylvania, USA Leonard Davis Institute of Health Economics
Career Start Year 1988
Number of shared co-authors 1
Mark S Roberts
School of Public Health, University of Pittsburgh
Career Start Year 1988
Number of shared co-authors 0
Robert S Epstein
Epstein Health LLC
Career Start Year 1988
Number of shared co-authors 0
Joel Tsevat
Dell Medical School, University of Texas at Austin
Career Start Year 1987
Number of shared co-authors 0
Sean Tunis
Center for Evaluation of Value and Risk in Health, Tufts Medical Center
Career Start Year 1987
Number of shared co-authors 0
Frank A Sonnenberg
Robert Wood Johnson Medical School, The State University of New Jersey
Career Start Year 1986
Number of shared co-authors 0
John B Wong
Tufts University School of Medicine
Career Start Year 1986
Number of shared co-authors 0
Benjamin Djulbegovic
Medical University of South Carolina
Career Start Year 1985
Number of shared co-authors 0
Theodore G Ganiats
university of california san diego
Career Start Year 1983
Number of shared co-authors 0
Mark Helfand
Oregon Health & Science University
Career Start Year 1983
Number of shared co-authors 0
Stan N Finkelstein
University of Toronto
Career Start Year 1977
Number of shared co-authors 0

Collaborators

Mike Paulden
School of Public Health, University of Alberta
Co-authored papers 18
Jeff Round
Institute of Health Economics, University of Alberta
Co-authored papers 10
Tania Bubela
Simon Fraser University
Co-authored papers 7
Janet A Dunn
Warwick Clinical Trials Unit, University of Warwick
Co-authored papers 6
Robert C Stein
12 University College London Hospitals National Health Service Foundation Trust
Co-authored papers 5
Timothy Caulfield
Faculty of Law and School of Public Health, University of Alberta
Co-authored papers 4
Douglas Sipp
RIKEN Center for Biosystems Dynamics Research
Co-authored papers 4
John M S Bartlett
University of Edinburgh
Co-authored papers 4
Kathryn M Rowan
Intensive Care National Audit & Research Centre (ICNARC)
Co-authored papers 3
Daniel Rea
Institute of Cancer and Genomic Sciences, The University of Birmingham
Co-authored papers 3
Jeremy Sugarman
Johns Hopkins University, Berman Institute of Bioethics
Co-authored papers 2
Paul Emery
Co-authored papers 2
Fran??ois Rousseau
Universite Laval
Co-authored papers 2
Megan Munsie
Stem Cell Ethics & Policy Group
Co-authored papers 2
George Davey Smith
University of Bristol
Co-authored papers 2
Shah Ebrahim
Co-authored papers 2
James Buchanan
Health Economics Research Centre, University of Oxford
Co-authored papers 2
Sarah Wordsworth
Health Economics Research Centre, University of Oxford
Co-authored papers 2
Carlos Caldas
Cancer Research UK Cambridge Institute, University of Cambridge
Co-authored papers 1
Kazuto Kato
Osaka University
Co-authored papers 1
Glenn Bauman
Western University and London Regional Cancer Program
Co-authored papers 1
Jim Evans
Co-authored papers 1
Cheryl Ho
University of British Columbia
Co-authored papers 1
Robert Cook-Deegan
Arizona State University.
Co-authored papers 1
Mildred K Cho
Center for Biomedical Ethics, Stanford University School of Medicine
Co-authored papers 1
Jack M Guralnik
Co-authored papers 1
Vardit Ravitsky (CM4AI)
The Hastings Center
Co-authored papers 1
Yann Joly
McGill University.
Co-authored papers 1
Fred Saad
University of Montreal Health Center
Co-authored papers 1
Barbara B Biesecker
and Translational Research Center
Co-authored papers 1
Release 1.2